Request for Covid-19 Impact Assessment of this Report
The United States OTC Anti-Infective Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global OTC Anti-Infective Drug market, reaching US$ million by the year 2028. As for the Europe OTC Anti-Infective Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main OTC Anti-Infective Drug players cover Bayer, GSK, Teva, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Anti-Infective Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Antifungal
Antibacterial
Antiviral
Antiseptics
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Drug Market Size 2017-2028
2.1.2 OTC Anti-Infective Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 OTC Anti-Infective Drug Segment by Type
2.2.1 Antifungal
2.2.2 Antibacterial
2.2.3 Antiviral
2.2.4 Antiseptics
2.2.5 Other
2.3 OTC Anti-Infective Drug Market Size by Type
2.3.1 OTC Anti-Infective Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global OTC Anti-Infective Drug Market Size Market Share by Type (2017-2022)
2.4 OTC Anti-Infective Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 OTC Anti-Infective Drug Market Size by Application
2.5.1 OTC Anti-Infective Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global OTC Anti-Infective Drug Market Size Market Share by Application (2017-2022)
3 OTC Anti-Infective Drug Market Size by Player
3.1 OTC Anti-Infective Drug Market Size Market Share by Players
3.1.1 Global OTC Anti-Infective Drug Revenue by Players (2020-2022)
3.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2020-2022)
3.2 Global OTC Anti-Infective Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OTC Anti-Infective Drug by Regions
4.1 OTC Anti-Infective Drug Market Size by Regions (2017-2022)
4.2 Americas OTC Anti-Infective Drug Market Size Growth (2017-2022)
4.3 APAC OTC Anti-Infective Drug Market Size Growth (2017-2022)
4.4 Europe OTC Anti-Infective Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa OTC Anti-Infective Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas OTC Anti-Infective Drug Market Size by Country (2017-2022)
5.2 Americas OTC Anti-Infective Drug Market Size by Type (2017-2022)
5.3 Americas OTC Anti-Infective Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Drug Market Size by Region (2017-2022)
6.2 APAC OTC Anti-Infective Drug Market Size by Type (2017-2022)
6.3 APAC OTC Anti-Infective Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC Anti-Infective Drug by Country (2017-2022)
7.2 Europe OTC Anti-Infective Drug Market Size by Type (2017-2022)
7.3 Europe OTC Anti-Infective Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Anti-Infective Drug by Region (2017-2022)
8.2 Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global OTC Anti-Infective Drug Market Forecast
10.1 Global OTC Anti-Infective Drug Forecast by Regions (2023-2028)
10.1.1 Global OTC Anti-Infective Drug Forecast by Regions (2023-2028)
10.1.2 Americas OTC Anti-Infective Drug Forecast
10.1.3 APAC OTC Anti-Infective Drug Forecast
10.1.4 Europe OTC Anti-Infective Drug Forecast
10.1.5 Middle East & Africa OTC Anti-Infective Drug Forecast
10.2 Americas OTC Anti-Infective Drug Forecast by Country (2023-2028)
10.2.1 United States OTC Anti-Infective Drug Market Forecast
10.2.2 Canada OTC Anti-Infective Drug Market Forecast
10.2.3 Mexico OTC Anti-Infective Drug Market Forecast
10.2.4 Brazil OTC Anti-Infective Drug Market Forecast
10.3 APAC OTC Anti-Infective Drug Forecast by Region (2023-2028)
10.3.1 China OTC Anti-Infective Drug Market Forecast
10.3.2 Japan OTC Anti-Infective Drug Market Forecast
10.3.3 Korea OTC Anti-Infective Drug Market Forecast
10.3.4 Southeast Asia OTC Anti-Infective Drug Market Forecast
10.3.5 India OTC Anti-Infective Drug Market Forecast
10.3.6 Australia OTC Anti-Infective Drug Market Forecast
10.4 Europe OTC Anti-Infective Drug Forecast by Country (2023-2028)
10.4.1 Germany OTC Anti-Infective Drug Market Forecast
10.4.2 France OTC Anti-Infective Drug Market Forecast
10.4.3 UK OTC Anti-Infective Drug Market Forecast
10.4.4 Italy OTC Anti-Infective Drug Market Forecast
10.4.5 Russia OTC Anti-Infective Drug Market Forecast
10.5 Middle East & Africa OTC Anti-Infective Drug Forecast by Region (2023-2028)
10.5.1 Egypt OTC Anti-Infective Drug Market Forecast
10.5.2 South Africa OTC Anti-Infective Drug Market Forecast
10.5.3 Israel OTC Anti-Infective Drug Market Forecast
10.5.4 Turkey OTC Anti-Infective Drug Market Forecast
10.5.5 GCC Countries OTC Anti-Infective Drug Market Forecast
10.6 Global OTC Anti-Infective Drug Forecast by Type (2023-2028)
10.7 Global OTC Anti-Infective Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer OTC Anti-Infective Drug Product Offered
11.1.3 Bayer OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK OTC Anti-Infective Drug Product Offered
11.2.3 GSK OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva OTC Anti-Infective Drug Product Offered
11.3.3 Teva OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson OTC Anti-Infective Drug Product Offered
11.4.3 Johnson & Johnson OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 NOVARTIS
11.5.1 NOVARTIS Company Information
11.5.2 NOVARTIS OTC Anti-Infective Drug Product Offered
11.5.3 NOVARTIS OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 NOVARTIS Main Business Overview
11.5.5 NOVARTIS Latest Developments
11.6 MYLAN
11.6.1 MYLAN Company Information
11.6.2 MYLAN OTC Anti-Infective Drug Product Offered
11.6.3 MYLAN OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 MYLAN Main Business Overview
11.6.5 MYLAN Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma OTC Anti-Infective Drug Product Offered
11.7.3 Sun Pharma OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 CR SANJIU
11.8.1 CR SANJIU Company Information
11.8.2 CR SANJIU OTC Anti-Infective Drug Product Offered
11.8.3 CR SANJIU OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 CR SANJIU Main Business Overview
11.8.5 CR SANJIU Latest Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla OTC Anti-Infective Drug Product Offered
11.9.3 Cipla OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cipla Main Business Overview
11.9.5 Cipla Latest Developments
11.10 Lingrui
11.10.1 Lingrui Company Information
11.10.2 Lingrui OTC Anti-Infective Drug Product Offered
11.10.3 Lingrui OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Lingrui Main Business Overview
11.10.5 Lingrui Latest Developments
12 Research Findings and Conclusion
Table 1. OTC Anti-Infective Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Antifungal
Table 3. Major Players of Antibacterial
Table 4. Major Players of Antiviral
Table 5. Major Players of Antiseptics
Table 6. Major Players of Other
Table 7. OTC Anti-Infective Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global OTC Anti-Infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global OTC Anti-Infective Drug Market Size Market Share by Type (2017-2022)
Table 10. OTC Anti-Infective Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global OTC Anti-Infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global OTC Anti-Infective Drug Market Size Market Share by Application (2017-2022)
Table 13. Global OTC Anti-Infective Drug Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global OTC Anti-Infective Drug Revenue Market Share by Player (2020-2022)
Table 15. OTC Anti-Infective Drug Key Players Head office and Products Offered
Table 16. OTC Anti-Infective Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global OTC Anti-Infective Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global OTC Anti-Infective Drug Market Size Market Share by Regions (2017-2022)
Table 21. Americas OTC Anti-Infective Drug Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas OTC Anti-Infective Drug Market Size Market Share by Country (2017-2022)
Table 23. Americas OTC Anti-Infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas OTC Anti-Infective Drug Market Size Market Share by Type (2017-2022)
Table 25. Americas OTC Anti-Infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas OTC Anti-Infective Drug Market Size Market Share by Application (2017-2022)
Table 27. APAC OTC Anti-Infective Drug Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC OTC Anti-Infective Drug Market Size Market Share by Region (2017-2022)
Table 29. APAC OTC Anti-Infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC OTC Anti-Infective Drug Market Size Market Share by Type (2017-2022)
Table 31. APAC OTC Anti-Infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC OTC Anti-Infective Drug Market Size Market Share by Application (2017-2022)
Table 33. Europe OTC Anti-Infective Drug Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe OTC Anti-Infective Drug Market Size Market Share by Country (2017-2022)
Table 35. Europe OTC Anti-Infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe OTC Anti-Infective Drug Market Size Market Share by Type (2017-2022)
Table 37. Europe OTC Anti-Infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe OTC Anti-Infective Drug Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa OTC Anti-Infective Drug Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of OTC Anti-Infective Drug
Table 46. Key Market Challenges & Risks of OTC Anti-Infective Drug
Table 47. Key Industry Trends of OTC Anti-Infective Drug
Table 48. Global OTC Anti-Infective Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global OTC Anti-Infective Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global OTC Anti-Infective Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global OTC Anti-Infective Drug Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global OTC Anti-Infective Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global OTC Anti-Infective Drug Market Size Market Share Forecast by Application (2023-2028)
Table 54. Bayer Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 55. Bayer OTC Anti-Infective Drug Product Offered
Table 56. Bayer OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Bayer Main Business
Table 58. Bayer Latest Developments
Table 59. GSK Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 60. GSK OTC Anti-Infective Drug Product Offered
Table 61. GSK Main Business
Table 62. GSK OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. GSK Latest Developments
Table 64. Teva Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 65. Teva OTC Anti-Infective Drug Product Offered
Table 66. Teva Main Business
Table 67. Teva OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Teva Latest Developments
Table 69. Johnson & Johnson Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 70. Johnson & Johnson OTC Anti-Infective Drug Product Offered
Table 71. Johnson & Johnson Main Business
Table 72. Johnson & Johnson OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Johnson & Johnson Latest Developments
Table 74. NOVARTIS Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 75. NOVARTIS OTC Anti-Infective Drug Product Offered
Table 76. NOVARTIS Main Business
Table 77. NOVARTIS OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. NOVARTIS Latest Developments
Table 79. MYLAN Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 80. MYLAN OTC Anti-Infective Drug Product Offered
Table 81. MYLAN Main Business
Table 82. MYLAN OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. MYLAN Latest Developments
Table 84. Sun Pharma Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 85. Sun Pharma OTC Anti-Infective Drug Product Offered
Table 86. Sun Pharma Main Business
Table 87. Sun Pharma OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Sun Pharma Latest Developments
Table 89. CR SANJIU Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 90. CR SANJIU OTC Anti-Infective Drug Product Offered
Table 91. CR SANJIU Main Business
Table 92. CR SANJIU OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. CR SANJIU Latest Developments
Table 94. Cipla Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 95. Cipla OTC Anti-Infective Drug Product Offered
Table 96. Cipla Main Business
Table 97. Cipla OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Cipla Latest Developments
Table 99. Lingrui Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 100. Lingrui OTC Anti-Infective Drug Product Offered
Table 101. Lingrui Main Business
Table 102. Lingrui OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Lingrui Latest Developments
List of Figures
Figure 1. OTC Anti-Infective Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global OTC Anti-Infective Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global OTC Anti-Infective Drug Market Size Market Share by Type in 2021
Figure 7. OTC Anti-Infective Drug in Hospital Pharmacies
Figure 8. Global OTC Anti-Infective Drug Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. OTC Anti-Infective Drug in Retail Pharmacies
Figure 10. Global OTC Anti-Infective Drug Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. OTC Anti-Infective Drug in Online Pharmacies
Figure 12. Global OTC Anti-Infective Drug Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global OTC Anti-Infective Drug Market Size Market Share by Application in 2021
Figure 14. Global OTC Anti-Infective Drug Revenue Market Share by Player in 2021
Figure 15. Global OTC Anti-Infective Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas OTC Anti-Infective Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC OTC Anti-Infective Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe OTC Anti-Infective Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa OTC Anti-Infective Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas OTC Anti-Infective Drug Value Market Share by Country in 2021
Figure 21. Americas OTC Anti-Infective Drug Consumption Market Share by Type in 2021
Figure 22. Americas OTC Anti-Infective Drug Market Size Market Share by Application in 2021
Figure 23. United States OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC OTC Anti-Infective Drug Market Size Market Share by Region in 2021
Figure 28. APAC OTC Anti-Infective Drug Market Size Market Share by Application in 2021
Figure 29. China OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe OTC Anti-Infective Drug Market Size Market Share by Country in 2021
Figure 36. Europe OTC Anti-Infective Drug Market Size Market Share by Type in 2021
Figure 37. Europe OTC Anti-Infective Drug Market Size Market Share by Application in 2021
Figure 38. Germany OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Application in 2021
Figure 46. Egypt OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country OTC Anti-Infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 59. China OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 63. India OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 66. France OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries OTC Anti-Infective Drug Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...